🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Single arm, Simon's two stage pilot study in which patients with ...
Status
Recruiting
Location
University of Illinois Cancer Center
Start Date
2024-12-16
Trial ID
NCT06576635
Treatments Being Tested
The purpose of this study is to compare the anti-tumor efficacy of oral sin...
Status
Terminated
Location
Comprehensive Blood and Cancer Center
Start Date
2015-02
Trial ID
NCT02322281
Treatments Being Tested
A prospective, single-arm, non-randomized, multi-center, open-label study f...
Status
Terminated
Location
Mayo Clinic Rochester
Start Date
2023-02-01
Trial ID
NCT05583188
This study is a multicenter, randomized, open-label Phase III trial that co...
Status
Unknown
Location
Binzhou Medical University Hospital
Start Date
2015-05
Trial ID
NCT02455843
Treatments Being Tested
This is a first-in-human (FIH), open-label, and multi-center Phase I/II stu...
Status
Recruiting
Location
START Los Angeles, LLC
Start Date
2025-02-24
Trial ID
NCT06741644
This was an open-label study to permit subjects with solid tumors or leukem...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2010-11-02
Trial ID
NCT01376310
The goal of IMMUNOLIFE2 is to overcome primary resistance to immune checkpo...
Status
Recruiting
Location
Centre Georges François Leclerc
Start Date
2025-11-17
Trial ID
NCT07001618
The hypothesize is that tepotinib is more effective than the investigator's...
Status
Recruiting
Location
Besançon - CHU
Start Date
2025-12-09
Trial ID
NCT06908993
To evaluate the efficacy and safety adebrelimab in Combination with chemoth...
Status
Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2024-05-19
Trial ID
NCT06424899
Treatments Being Tested
The primary objective of this study is to compare the overall survival (OS)...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2023-04-06
Trial ID
NCT05754853